Citation: I. Hozo et B. Djulbegovic, CALCULATING CONFIDENCE-INTERVALS FOR THRESHOLD AND POSTTEST PROBABILITIES, M.D. computing, 15(2), 1998, pp. 110-115
Citation: B. Djulbegovic et I. Hozo, LINKING EVIDENCE-BASED MEDICINE (EBM) TO CLINICAL DECISION-ANALYSIS (CDA), Medical decision making, 18(4), 1998, pp. 464-464
Citation: B. Djulbegovic et al., THE VALUE OF HEMATOCRIT IN THE DIAGNOSIS OF POLYCYTHEMIA-VERA, British Journal of Haematology, 102(1), 1998, pp. 312-312
Citation: C. Tecimer et al., IS STANDARD HEPARIN SUPERIOR TO LOW-MOLECULAR-WEIGHT HEPARIN IN MALIGNANCY RELATED DEEP-VEIN THROMBOSIS, Blood, 90(10), 1997, pp. 3265-3265
Authors:
DJULBEGOVIC B
GOLDSMITH G
VAUGHN D
BIRKIMER J
MARASA M
JOSEPH G
HUANG A
HADLEY T
Citation: B. Djulbegovic et al., COMPARISON OF THE QUALITY-OF-LIFE BETWEEN HIV-POSITIVE HEMOPHILIA PATIENTS AND HIV-NEGATIVE HEMOPHILIA PATIENTS, Haemophilia, 2(3), 1996, pp. 166-172
Authors:
DJULBEGOVIC B
MARASA M
PESTO A
KUSHNER GM
HADLEY T
JOSEPH G
GOLDSMITH G
Citation: B. Djulbegovic et al., SAFETY AND EFFICACY OF PURIFIED FACTOR-IX CONCENTRATE AND ANTIFIBRINOLYTIC AGENTS FOR DENTAL EXTRACTIONS IN HEMOPHILIA-B, American journal of hematology, 51(2), 1996, pp. 168-170
Authors:
FLEMING D
GOLDSMITH J
GOLDSMITH G
DJULBEGOVIC B
STEVENS D
CEVERA A
HERZIG R
Citation: D. Fleming et al., DETERMINANTS OF HEMATOPOIETIC RECOVERY FOLLOWING AUTOLOGOUS STEM-CELLTRANSPLANTATION (SCT), Experimental hematology, 24(9), 1996, pp. 103-103
Citation: B. Djulbegovic et Ah. Desoky, EQUATION AND NOMOGRAM FOR CALCULATION OF TESTING AND TREATMENT THRESHOLDS, Medical decision making, 16(2), 1996, pp. 198-199
Citation: B. Djulbegovic et al., INFORMATION CONTENTS OF THE POLYCYTHEMIA-VERA STUDY-GROUP (PVSG) DIAGNOSTIC-CRITERIA, Blood, 88(10), 1996, pp. 3545-3545
Citation: B. Djulbegovic, LACK OF PROPHYLACTIC ANTICOAGULANT-THERAPY IS NOT ASSOCIATED WITH CLINICAL THROMBOTIC COMPLICATIONS IN PATIENTS WITH HEMOPHILIA WHO UNDERGOORTHOPEDIC SURGICAL-PROCEDURES, American journal of hematology, 50(3), 1995, pp. 229-230
Citation: B. Djulbegovic, COST-EFFECTIVENESS (CE) OF MONOCLONAL-ANTIBODY (MAB)-PURIFIED FACTOR-IX VERSUS PROTHROMBIN COMPLEX CONCENTRATE (PCC) IN THE TREATMENT OF HEMOPHILIA-B PATIENTS UNDERGOING KNEE SURGERY, Thrombosis and haemostasis, 73(6), 1995, pp. 1036-1036
Authors:
WHITE GC
SHAPIRO AD
KURCZYNSKI EM
KIM HC
BERGMAN GE
BENJAMIN L
BROOKS P
CORNELL NJ
CZAPEK E
DAVIS RT
DIMICHELE D
DJULBEGOVIC B
GILL JC
GOLDSMITH J
GORDON ME
GREEN D
GREENBERG S
GRIBBLE J
HILGARTNER M
HODDER F
HUTTER JJ
JANCO R
KASPER C
KESSLER C
LUSHER J
MARTINOWITZ U
OPENSHAW TH
PHILLIPS M
PITEL P
POTOLSKY A
PRESTON FE
RAUSEN A
SAVIDGE G
SEXAUER C
SHURAFA M
SMITH G
SWEENEY J
TELFORD M
WILDE J
WILSON W
Citation: Gc. White et al., VARIABILITY OF IN-VIVO RECOVERY OF FACTOR-IX AFTER INFUSION OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX CONCENTRATES IN PATIENTS WITH HEMOPHILIA-B, Thrombosis and haemostasis, 73(5), 1995, pp. 779-784
Citation: B. Djulbegovic et G. Goldsmith, BAYESIAN VALIDATION OF POLYCYTHEMIA-VERA STUDY-GROUP CRITERIA FOR DIAGNOSIS OF POLYCYTHEMIA RUBRA VERA, Blood, 86(10), 1995, pp. 3161-3161
Citation: B. Djulbegovic et al., CONCOMITANT TREATMENT WITH FACTOR-IX CONCENTRATES AND ANTIFIBRINOLYTICS IN HEMOPHILIA-B, Acta haematologica, 94, 1995, pp. 43-48
Authors:
JOSEPH G
SMITH KJ
HADLEY TJ
DJULBEGOVIC B
TROUP GM
OLDFATHER J
BARKER RL
Citation: G. Joseph et al., HLA-DR53 PROTECTS AGAINST THROMBOTIC THROMBOCYTOPENIC PURPURA ADULT HEMOLYTIC-UREMIC SYNDROME, American journal of hematology, 47(3), 1994, pp. 189-193
Citation: B. Djulbegovic et al., IS PROPHYLACTIC ANTICOAGULANT-THERAPY NECESSARY FOR HEMOPHILIA PATIENTS UNDERGOING ORTHOPEDIC SURGICAL-PROCEDURES, Blood, 84(10), 1994, pp. 10000200-10000200
Citation: B. Djulbegovic et Hc. Kim, COMPASSIONATE TREATMENT WITH A MONOCLONAL ANTIBODY-PURIFIED FACTOR-IXCONCENTRATE IN HEMOPHILIA-B SURGICAL PATIENTS WHO HAVE EXPERIENCED THROMBOTIC COMPLICATIONS WITH PROTHROMBIN COMPLEX CONCENTRATES, Blood, 82(10), 1993, pp. 10000154-10000154